Michael Heindel
About Michael Heindel
Michael Heindel is a Medical Scientist Lead in Oncology and Cell Therapy at Kite Pharma, serving as Associate Director since 2022. He has extensive experience in the pharmaceutical industry, having held various roles in medical science liaison and regional management at companies such as Biogen, Celgene, and Bristol Myers Squibb.
Work at Kite Pharma
Michael Heindel currently serves as the Medical Scientist Lead for Oncology and Cell Therapy (CAR-T) at Kite Pharma. He has held this position since 2022, contributing to the company's focus on innovative cancer therapies. His role involves leading scientific initiatives and collaborating with various stakeholders to advance CAR-T cell therapies.
Previous Experience in the Pharmaceutical Industry
Before joining Kite Pharma, Michael Heindel accumulated extensive experience in the pharmaceutical sector. He worked at Biogen in various roles, including Medical Science Liaison and Area Business Manager, from 2004 to 2017. He also held positions at Celgene as Regional Medical Liaison and Lead Regional Medical Liaison from 2018 to 2021, and at Bristol Myers Squibb as Head of Medical Science Liaison for Immunology and Fibrosis in 2021.
Education and Expertise
Michael Heindel studied at Technische Hochschule Mittelhessen, where he earned a Diplom-Ingenieur in Biotechnology from 1993 to 1997. He also attended Philipps-Universität Marburg, focusing on Biology and Microbiology for one year in 1997. His educational background supports his expertise in medical science and oncology.
Career Progression
Michael Heindel's career in the pharmaceutical industry began at Cephalon, where he worked in various roles from 2004 to 2008, including Außendienstmitarbeiter and Regionaler Vertriebsleiter. His career progressed through significant positions at Biogen and Celgene, leading to his current role at Kite Pharma. This trajectory highlights his growth and development in medical science and leadership.